Literature DB >> 9556129

Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures.

M M Hurley1, S K Lee, L G Raisz, P Bernecker, J Lorenzo.   

Abstract

We determined the effect of basic fibroblast growth factor (bFGF) on osteoclast-like cell (OCL) formation in bone marrow cultures using C57BL/6 mice. Cells were cultured for 7 days with or without bFGF at various concentrations or 10(-8) mol/L 1,25(OH)2 vitamin D3 [1,25(OH)2D3]. bFGF dose-dependently increased OCL formation per well (10(-10) mol/ L = 40 +/- 2; 10(-9) mol/L = 146 +/- 13; 10(-8) mol/L = 156 +/- 12) compared with control (< 7 per well). The effects of bFGF at 10(-9) and 10(-8) mol/L were similar to that of 10(-8) mol/L 1,25(OH)2D3 (154 +/- 11 per well). OCLs formed by bFGF were multinuclear, tartrate-resistant acid phosphatase (TRAP)-positive, expressed calcitonin receptors, and formed characteristic resorption pits. We also determined whether bFGF enhanced OCL formation during the early proliferative or late differentiating phases of the cultures. When bFGF (10(-8) mol/L) was added only on days 1-2 or days 3-4 of 6 day cultures, there was a significant increase in OCL formation. In contrast, when bFGF was added only on days 5-6 few OCLs formed. Addition of bFGF at days 1-6 or days 1-2 and days 5-6 caused similar increases in OCL formation, which were greater than OCL formation induced by treatment for days 1-2 or days 1-4. We examined the production of prostaglandin E2 (PGE2) in the cultures because bFGF is a potent stimulator of PGE2 synthesis in bone, and PGE2 stimulates OCL formation. bFGF treatment significantly increased PGE2 levels in 7 day cultures (controls = 1.4 +/- 0.1 nmol/L, 10(-8) mol/L bFGF = 132.5 +/- 0.7 nmol/L). In addition, treatment of marrow cultures with the prostaglandin synthesis inhibitors, indomethacin or NS-398 (both at 10(-6) mol/L), completely blocked bFGF-induced OCL formation. We conclude that bFGF stimulates OCL formation in C57BL/6 bone marrow cultures by mechanisms that require prostaglandin synthesis. This pathway is likely to be one mechanism by which bFGF stimulates resorption.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9556129     DOI: 10.1016/s8756-3282(97)00292-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  18 in total

1.  The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice.

Authors:  Yingben Xue; Yongjun Xiao; Jingning Liu; Andrew C Karaplis; Martin R Pollak; Edward M Brown; Dengshun Miao; David Goltzman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-24       Impact factor: 4.310

2.  Characterization of a new renal cell carcinoma bone metastasis mouse model.

Authors:  Anne Strube; Elizaveta Stepina; Dominik Mumberg; Arne Scholz; Peter Hauff; Sanna-Maria Käkönen
Journal:  Clin Exp Metastasis       Date:  2010-05-05       Impact factor: 5.150

3.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.

Authors:  A Montero; Y Okada; M Tomita; M Ito; H Tsurukami; T Nakamura; T Doetschman; J D Coffin; M M Hurley
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.

Authors:  Y Okada; J A Lorenzo; A M Freeman; M Tomita; S G Morham; L G Raisz; C C Pilbeam
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  The investigation of synovial genomic targets of bucillamine with microarray technique.

Authors:  Kenji Oki; Fumio Tsuji; Koji Ohashi; Masaaki Kageyama; Hiroyuki Aono; Minoru Sasano
Journal:  Inflamm Res       Date:  2009-03-17       Impact factor: 4.575

6.  Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.

Authors:  Se Hwan Mun; Hee Yeon Won; Paula Hernandez; Hector Leonardo Aguila; Sun-Kyeong Lee
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

7.  DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells.

Authors:  Kumaran Sundaram; Santhosh K Mani; Kazuyuki Kitatani; Kongming Wu; Richard G Pestell; Sakamuri V Reddy
Journal:  J Cell Biochem       Date:  2008-04-15       Impact factor: 4.429

8.  Basic fibroblast growth factor has rapid bone anabolic effects in ovariectomized rats.

Authors:  R A Power; U T Iwaniec; K A Magee; N G Mitova-Caneva; T J Wronski
Journal:  Osteoporos Int       Date:  2004-03-30       Impact factor: 4.507

9.  Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model.

Authors:  N E Lane; J Kumer; W Yao; T Breunig; T Wronski; G Modin; J H Kinney
Journal:  Osteoporos Int       Date:  2003-05-24       Impact factor: 4.507

10.  Establishment of an animal model of a pasteurized bone graft, with a preliminary analysis of muscle coverage or FGF-2 administration to the graft.

Authors:  Tatsuya Yoshida; Akio Sakamoto; Nobuaki Tsukamoto; Koichi Nakayama; Yukihide Iwamoto
Journal:  J Orthop Surg Res       Date:  2009-08-04       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.